Editorial on “Hypermetabolic State Drives Platelet Dysfunction in Human and Mouse Metabolic Dysfunction–Associated Steatotic Liver Disease”
Arteriosclerosis, Thrombosis, and Vascular Biology · 29.10.2026
DOI: 10.1161/atvbaha.126.325659 ↗Kurz gefasst
Editorial in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, online erschienen am 29.10.2026. Verfasst von Andrew L Frelinger. Beteiligte Einrichtung: Faculty, Dana Farber/Boston Children's Cancer and Blood Disorders Center, MA (A.L.F.). Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty, Dana Farber/Boston Children's Cancer and Blood Disorders Center, MA (A.L.F.).
- Department of Pediatrics, Harvard Medical School, Boston, MA (A.L.F.).
- Platelet Research Associates, LLC, North Andover, MA (A.L.F.).
ORCID-Profile: Andrew L Frelinger
Zitieren
APA
Frelinger, A. L. (2026). Editorial on “Hypermetabolic State Drives Platelet Dysfunction in Human and Mouse Metabolic Dysfunction–Associated Steatotic Liver Disease”. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.126.325659
Vancouver
Frelinger AL. Editorial on “Hypermetabolic State Drives Platelet Dysfunction in Human and Mouse Metabolic Dysfunction–Associated Steatotic Liver Disease”. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.126.325659
BibTeX
@article{Frelinger2026,
author = {Frelinger, Andrew L},
title = {Editorial on “Hypermetabolic State Drives Platelet Dysfunction in Human and Mouse Metabolic Dysfunction–Associated Steatotic Liver Disease”},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
doi = {10.1161/atvbaha.126.325659}
}
EUVIMED